BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«KIR2DL2

Below is an extended KIR2DL2 research listing. Click here to return to the KIR2DL2 main in depth entry.

Recent Publications on KIR2DL2:

Investigation of killer cell immunoglobulin-like receptor (KIR) gene diversity: KIR2DL2, KIR2DL5 and KIR2DS5.
Human killer cell immunoglobulin-like receptor (KIR) genes are important...
Direct Link
6th September, 2008
Northern Ireland Regional Histocompatibility and Immunogenetics
Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.
To determine whether killer cell immunologlobulin-like receptor (KIR)...
Direct Link
30th August, 2008
Division of Rheumatology, Centre for Prognosis studies in the Rheumatic
Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes. 14th August, 2008
Institut National de la Sante et de la Recherche Medicale Unite 841,
Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5.
In the human killer cell immunoglobulin-like receptors, KIR2DL2, and...
Direct Link
7th August, 2008
Department of Oncology, Lombardi Cancer Center, Georgetown University,
Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.
Birdshot chorioretinopathy (BCR), a chronic ocular inflammatory disease...
Direct Link
17th July, 2008
Ocular Inflammatory Disease Center, Jules Stein Eye Institute, David
[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation] 12th July, 2008
Department of Hematology, General Hospital of Chinese People's Liberation
Killer immunoglobulin-like receptor repertoire on uterine natural killer cell subsets in women with recurrent spontaneous abortions.
OBJECTIVE: The objective of this study is to investigate the distribution...
Direct Link
24th June, 2008
Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao
Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. 11th June, 2008
Department of Structural Biology, School of Medicine, Stanford University,
CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sezary syndrome by flow cytometry.
Enumeration of neoplastic T-cells in peripheral blood specimens is...
Direct Link
5th June, 2008
Department of Pathology, University of Utah, Salt Lake City, Utah 84132,
Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack.
Hair follicles (HFs) enjoy a relative immune privilege (IP) that is...
Direct Link
20th May, 2008
Department of Dermatology, Hamamatsu University School of Medicine,
Description of two new HLA-C alleles in a black South African population.
Two new HLA-C alleles, Cw*0333 and Cw*0217, were identified in a Black...
Direct Link
1st May, 2008
Department of Medicine, College of Physicians and Surgeons, Columbia
Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.
We investigated whether killer cell immunoglobulin-like receptor (KIR)...
Direct Link
9th February, 2008
Department of Clinical Immunology, Ludwik Hirszfeld Institute of
KIR/HLA ligand incompatibility in kidney transplantation.
BACKGROUND: The polymorphic family of killer-cell immunoglobulin-like...
Direct Link
30th January, 2008
Institute of Medical Immunology, Charite Universitatsmedizin Berlin,
[Analysis of natural killer cell immunoglobulin-like receptor gene family in HLA-identical sibling] 20th December, 2007
Blood Center of Zhejiang Province, Key Laboratory of Blood Safety
[Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT] 15th December, 2007
Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional